ir.juniperpharma.com ir.juniperpharma.com

ir.juniperpharma.com

Juniper Pharmaceuticals | Investor Relations Overview

Juniper Pharmaceuticals (Nasdaq: JNP) address unmet and underserved medical needs in women's health. Our product pipeline leverages our highly differentiated intravaginal ring ("IVR") technology. Which we expect will offer multiple benefits to patients. Current 505(b)(2) candidates include:. An oxybutynin IVR for the treatment of overactive bladder in women;. A combination estradiol progesterone IVR for hormone replacement therapy; and,. A natural progesterone IVR for the prevention of preterm birth.

http://ir.juniperpharma.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.JUNIPERPHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

August

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 11 reviews
5 star
2
4 star
6
3 star
1
2 star
0
1 star
2

Hey there! Start your review of ir.juniperpharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.9 seconds

CONTACTS AT IR.JUNIPERPHARMA.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Juniper Pharmaceuticals | Investor Relations Overview | ir.juniperpharma.com Reviews
<META>
DESCRIPTION
Juniper Pharmaceuticals (Nasdaq: JNP) address unmet and underserved medical needs in women's health. Our product pipeline leverages our highly differentiated intravaginal ring (IVR) technology. Which we expect will offer multiple benefits to patients. Current 505(b)(2) candidates include:. An oxybutynin IVR for the treatment of overactive bladder in women;. A combination estradiol progesterone IVR for hormone replacement therapy; and,. A natural progesterone IVR for the prevention of preterm birth.
<META>
KEYWORDS
1 about us
2 corporate news
3 investor relations
4 corporate home
5 investor relations overview
6 news and events
7 presentations
8 corporate governance
9 sec filings
10 financial information
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,corporate news,investor relations,corporate home,investor relations overview,news and events,presentations,corporate governance,sec filings,financial information,stock information,analyst coverage,investor faq,investor toolkit,print page,progest
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Juniper Pharmaceuticals | Investor Relations Overview | ir.juniperpharma.com Reviews

https://ir.juniperpharma.com

Juniper Pharmaceuticals (Nasdaq: JNP) address unmet and underserved medical needs in women's health. Our product pipeline leverages our highly differentiated intravaginal ring ("IVR") technology. Which we expect will offer multiple benefits to patients. Current 505(b)(2) candidates include:. An oxybutynin IVR for the treatment of overactive bladder in women;. A combination estradiol progesterone IVR for hormone replacement therapy; and,. A natural progesterone IVR for the prevention of preterm birth.

OTHER SITES

ir.jkuat.ac.ke ir.jkuat.ac.ke

Repository Home

JavaScript is disabled for your browser. Some features of this site may not work without it. Welcome to the JKUAT Institutional repository that collects, preserves, and distributes digital materials available at Jomo Kenyatta University of Agriculture and Technology. Select a community to browse its collections. University projects and collaborations. Technical and economic assessment of adopting under-balanced drilling at the Olkaria geothermal field. Nzioka, Felix Kiio. Kipngeno, Langat Hillary. Driver...

ir.jmsc.co.jp ir.jmsc.co.jp

MS-Japan IR情報TOP - IR情報|管理部門特化型エージェント№1エージェント-株式会社MS-Japan

弁護士 公認会計士 税理士等の士業資格者と管理部門のためのコミュニティサイト Manegy(マネジー) 士業向けの先行ユーザー登録受付2017年1月中旬に開始. 管理部門特化型エージェントNo.1 MS-Japan エムエス ジャパン. 経理 財務,人事,法務,税理士,公認会計士,会計事務所 監査法人,弁護士の求人、転職サポートは管理部門特化型エージェントNo.1 MS-Japan エムエス ジャパン.

ir.joe.com ir.joe.com

The St. Joe Company - Investor Overview

Don't Have An Account? Port of Port St. Joe. Up to $100,000. 100,000 - $250,000. 250,000 - $500,000. 500,000 - $1,000,000. 1,000,000 and up. Beach Club for Residence. About St. Joe. Regulation FD Disclosure Policy. March 19, 2018. Statement of Changes of Beneficial Ownership. March 19, 2018. Statement of Changes of Beneficial Ownership. March 19, 2018. Statement of Changes of Beneficial Ownership. The St. Joe Company. 133 South WaterSound Parkway. WaterSound, Florida 32461. View all releases ».

ir.jse.co.za ir.jse.co.za

JSE - Investor Relations - Company Overview

Turn on more accessible mode. Turn off more accessible mode. Companies and Issuer Regulation. Companies and other Issuers. Listing on the JSE. Find a Designated Advisor or Sponsor. Becoming a Trading Member. Markets, Regulation and Trade Operations. Fixed Income Index Series. FTSE/JSE Africa Index Series. Socially Responsible Investment (SRI) Index. Welcome to Investor Relations. JSE 2014 Integrated Annual Report. SENS announcement: JSE 2014 Annual Results. Presentation: 2014 Annual Results.

ir.jsl.com.br ir.jsl.com.br

JSL | Investor Relation

Mission, Vision and Values. Strategies and Competitive Advantages. Management, Board of Directors and Fiscal Council. Financial and Procurement Committee. Presentations and Conference Calls. Quotes and Charts - B3. JSL s ADR level I Program. Social and Environmental Responsability. Key impacts from the Business. Expertise in developing and implementing customized logistics solutions. Exposure to the growth of the Brazilian economy. Strong reputation and market recognition. You must have a RSS. Material F...

ir.juniperpharma.com ir.juniperpharma.com

Juniper Pharmaceuticals | Investor Relations Overview

Juniper Pharmaceuticals (Nasdaq: JNP) address unmet and underserved medical needs in women's health. Our product pipeline leverages our highly differentiated intravaginal ring ("IVR") technology. Which we expect will offer multiple benefits to patients. Current 505(b)(2) candidates include:. An oxybutynin IVR for the treatment of overactive bladder in women;. A combination estradiol progesterone IVR for hormone replacement therapy; and,. A natural progesterone IVR for the prevention of preterm birth.

ir.junotherapeutics.com ir.junotherapeutics.com

Investor Relations | Juno Therapeutics

Juno Therapeutics is a clinical-stage company developing novel cellular immunotherapies based on two distinct and complementary platforms Chimeric Antigen Receptors (CARs) and T Cell Receptors (TCRs) technologies. Our goal is to revolutionize medicine by re-engaging the body’s immune system to treat cancer. Q2 2015 Juno Therapeutics Earnings Conference Call. August 12, 2015. 160;at 2:00 pm PT. Q2 2015 Juno Therapeutics Earnings Conference Call. Wednesday, August 12, 2015 . 2:00 pm PT  . Aug 12, 2015.

ir.k-sea.com ir.k-sea.com

k-sea.com - This website is for sale! - k sea ksea tugs towing barge barges oil barge bunker bunkers oil delivery Resources and Information.

The owner of k-sea.com. Is offering it for sale for an asking price of 499 USD! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.

ir.kabarak.ac.ke ir.kabarak.ac.ke

Home

JavaScript is disabled for your browser. Some features of this site may not work without it. The Repository is a digital service that collects, preserves, and distributes digital material. It serves as the home for the intellectual output of the Kabarak University academic communities, and will ultimately include digital dissertations, faculty publications, digital special collections, open access publications, open educational resources and much more. Select a community to browse its collections. Entrep...

ir.kadokawa.co.jp ir.kadokawa.co.jp

株式会社KADOKAWA 企業情報

電撃文庫のファン感謝イベント 電撃文庫 秋の祭典2015 10月4日 秋葉原にて開催、ステージ サイン会の参加応募受付中 アスキー メディアワークス. 大感謝フェア 開催中 アスキー メディアワークス. ジョーカー ゲーム TVアニメ化決定 公式サイトオープン スタッフ公開. 艦これ 劇場版 制作開始 2016年公開. 板野友美、ホラー映画で初主演 のぞきめ 2016年春 全国ロードショー. 初野晴の大人気 吹奏楽青春ミステリ ハルチカ シリーズ ハルチカ ハルタとチカは青春する 豪華スタッフで2016年1月TVアニメ放送開始予定.

ir.kalobios.com ir.kalobios.com

KaloBios - Investor Relations

Strategy for Producing Humaneered Antibodies. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put KaloBios financial performance into perspective. View all ». Aug 10, 2015. KaloBios Reports Second Quarter Financial Results and Provides Clinical Update. Jul 29, 2015. KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia.